- Report
- January 2025
- 255 Pages
Global
From €7015EUR$7,950USD£6,067GBP
- Report
- January 2025
- 880 Pages
Global
From €7015EUR$7,950USD£6,067GBP
- Report
- December 2024
- 122 Pages
Global
From €3485EUR$3,950USD£3,014GBP
- Report
- December 2024
- 114 Pages
Global
From €3485EUR$3,950USD£3,014GBP
- Report
- December 2024
- 131 Pages
Global
From €3485EUR$3,950USD£3,014GBP
- Report
- December 2024
- 71 Pages
Global
From €3485EUR$3,950USD£3,014GBP
- Report
- August 2025
- 188 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- July 2025
- 188 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- March 2025
- 180 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- August 2025
- 138 Pages
Global
From €2646EUR$2,999USD£2,289GBP
- Report
- May 2025
- 142 Pages
Global
From €2646EUR$2,999USD£2,289GBP
- Report
- May 2025
- 139 Pages
Global
From €2646EUR$2,999USD£2,289GBP
- Report
- January 2025
- 125 Pages
Global
From €2646EUR$2,999USD£2,289GBP
- Report
- January 2025
- 142 Pages
Global
From €2646EUR$2,999USD£2,289GBP
- Report
- January 2025
- 133 Pages
Global
From €2646EUR$2,999USD£2,289GBP
- Report
- January 2025
- 135 Pages
Global
From €2646EUR$2,999USD£2,289GBP
- Report
- September 2025
- 281 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 470 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 299 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 271 Pages
Global
From €5162EUR$5,850USD£4,465GBP

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more